Special Reports
Melanoma (Issue 1)
Volume: 1
Issue: 1
NSCLC (Issue 1)
Volume: 1
Issue: 1
Immunotherapy (Issue 1)
Volume: 1
Issue: 1
B-Cell Malignancies
Volume: 1
Issue: 1
Genitourinary Cancers
Volume: 1
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
4
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
5